These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8988956)

  • 1. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
    Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
    Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
    Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS
    Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial.
    Sacristán JA; Gilaberte I; Boto B; Buesching DP; Obenchain RL; Demitrack M; Pérez Sola V; Alvarez E; Artigas F
    Int Clin Psychopharmacol; 2000 Mar; 15(2):107-13. PubMed ID: 10759342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
    Reimherr FW; Amsterdam JD; Quitkin FM; Rosenbaum JF; Fava M; Zajecka J; Beasley CM; Michelson D; Roback P; Sundell K
    Am J Psychiatry; 1998 Sep; 155(9):1247-53. PubMed ID: 9734550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pindolol augmentation of treatment-resistant depressed patients.
    Moreno FA; Gelenberg AJ; Bachar K; Delgado PL
    J Clin Psychiatry; 1997 Oct; 58(10):437-9. PubMed ID: 9375594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
    Zhang WJ; Yang XB; Zhong BL
    J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study.
    Thakore JH; Dinan TG
    Am J Psychiatry; 1995 Apr; 152(4):616-8. PubMed ID: 7694914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
    Fava M; Amsterdam JD; Deltito JA; Salzman C; Schwaller M; Dunner DL
    Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors.
    Pérez V; Puiigdemont D; Gilaberte I; Alvarez E; Artigas F;
    J Clin Psychopharmacol; 2001 Feb; 21(1):36-45. PubMed ID: 11199945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
    Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY
    J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.